The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Rotavirus Infection Therapeutics Market Research Report 2025
Synopsis
Rotavirus (RV) is a double-stranded ribonucleic acid virus, which belongs to the reovirus family. It is the single leading cause of diarrhea in infants and young children, and almost every child in the world around the age of five has been infected with rotavirus at least once.
The global Rotavirus Infection Therapeutics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Rotavirus Infection Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rotavirus Infection Therapeutics.
Report Scope
The Rotavirus Infection Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Rotavirus Infection Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rotavirus Infection Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GlaxoSmithKline
Bharat Biotech
Curevac
Ology Bioservices
BioKangtai
Segment by Type
Oral Drug
Injiectable Drug
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Rotavirus Infection Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Rotavirus (RV) is a double-stranded ribonucleic acid virus, which belongs to the reovirus family. It is the single leading cause of diarrhea in infants and young children, and almost every child in the world around the age of five has been infected with rotavirus at least once.
The global Rotavirus Infection Therapeutics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Rotavirus Infection Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rotavirus Infection Therapeutics.
Report Scope
The Rotavirus Infection Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Rotavirus Infection Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rotavirus Infection Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GlaxoSmithKline
Bharat Biotech
Curevac
Ology Bioservices
BioKangtai
Segment by Type
Oral Drug
Injiectable Drug
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Rotavirus Infection Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Rotavirus Infection Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Oral Drug
1.2.3 Injiectable Drug
1.3 Market by Application
1.3.1 Global Rotavirus Infection Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Rotavirus Infection Therapeutics Market Perspective (2019-2030)
2.2 Rotavirus Infection Therapeutics Growth Trends by Region
2.2.1 Global Rotavirus Infection Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Rotavirus Infection Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Rotavirus Infection Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Rotavirus Infection Therapeutics Market Dynamics
2.3.1 Rotavirus Infection Therapeutics Industry Trends
2.3.2 Rotavirus Infection Therapeutics Market Drivers
2.3.3 Rotavirus Infection Therapeutics Market Challenges
2.3.4 Rotavirus Infection Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Rotavirus Infection Therapeutics Players by Revenue
3.1.1 Global Top Rotavirus Infection Therapeutics Players by Revenue (2019-2024)
3.1.2 Global Rotavirus Infection Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Rotavirus Infection Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Rotavirus Infection Therapeutics Revenue
3.4 Global Rotavirus Infection Therapeutics Market Concentration Ratio
3.4.1 Global Rotavirus Infection Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Rotavirus Infection Therapeutics Revenue in 2023
3.5 Rotavirus Infection Therapeutics Key Players Head office and Area Served
3.6 Key Players Rotavirus Infection Therapeutics Product Solution and Service
3.7 Date of Enter into Rotavirus Infection Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Rotavirus Infection Therapeutics Breakdown Data by Type
4.1 Global Rotavirus Infection Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Rotavirus Infection Therapeutics Forecasted Market Size by Type (2025-2030)
5 Rotavirus Infection Therapeutics Breakdown Data by Application
5.1 Global Rotavirus Infection Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Rotavirus Infection Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Rotavirus Infection Therapeutics Market Size (2019-2030)
6.2 North America Rotavirus Infection Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Rotavirus Infection Therapeutics Market Size by Country (2019-2024)
6.4 North America Rotavirus Infection Therapeutics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Rotavirus Infection Therapeutics Market Size (2019-2030)
7.2 Europe Rotavirus Infection Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Rotavirus Infection Therapeutics Market Size by Country (2019-2024)
7.4 Europe Rotavirus Infection Therapeutics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Rotavirus Infection Therapeutics Market Size (2019-2030)
8.2 Asia-Pacific Rotavirus Infection Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Rotavirus Infection Therapeutics Market Size by Region (2019-2024)
8.4 Asia-Pacific Rotavirus Infection Therapeutics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Rotavirus Infection Therapeutics Market Size (2019-2030)
9.2 Latin America Rotavirus Infection Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Rotavirus Infection Therapeutics Market Size by Country (2019-2024)
9.4 Latin America Rotavirus Infection Therapeutics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Rotavirus Infection Therapeutics Market Size (2019-2030)
10.2 Middle East & Africa Rotavirus Infection Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Rotavirus Infection Therapeutics Market Size by Country (2019-2024)
10.4 Middle East & Africa Rotavirus Infection Therapeutics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Detail
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Rotavirus Infection Therapeutics Introduction
11.1.4 GlaxoSmithKline Revenue in Rotavirus Infection Therapeutics Business (2019-2024)
11.1.5 GlaxoSmithKline Recent Development
11.2 Bharat Biotech
11.2.1 Bharat Biotech Company Detail
11.2.2 Bharat Biotech Business Overview
11.2.3 Bharat Biotech Rotavirus Infection Therapeutics Introduction
11.2.4 Bharat Biotech Revenue in Rotavirus Infection Therapeutics Business (2019-2024)
11.2.5 Bharat Biotech Recent Development
11.3 Curevac
11.3.1 Curevac Company Detail
11.3.2 Curevac Business Overview
11.3.3 Curevac Rotavirus Infection Therapeutics Introduction
11.3.4 Curevac Revenue in Rotavirus Infection Therapeutics Business (2019-2024)
11.3.5 Curevac Recent Development
11.4 Ology Bioservices
11.4.1 Ology Bioservices Company Detail
11.4.2 Ology Bioservices Business Overview
11.4.3 Ology Bioservices Rotavirus Infection Therapeutics Introduction
11.4.4 Ology Bioservices Revenue in Rotavirus Infection Therapeutics Business (2019-2024)
11.4.5 Ology Bioservices Recent Development
11.5 BioKangtai
11.5.1 BioKangtai Company Detail
11.5.2 BioKangtai Business Overview
11.5.3 BioKangtai Rotavirus Infection Therapeutics Introduction
11.5.4 BioKangtai Revenue in Rotavirus Infection Therapeutics Business (2019-2024)
11.5.5 BioKangtai Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Rotavirus Infection Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Oral Drug
Table 3. Key Players of Injiectable Drug
Table 4. Global Rotavirus Infection Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Rotavirus Infection Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Rotavirus Infection Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Rotavirus Infection Therapeutics Market Share by Region (2019-2024)
Table 8. Global Rotavirus Infection Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Rotavirus Infection Therapeutics Market Share by Region (2025-2030)
Table 10. Rotavirus Infection Therapeutics Market Trends
Table 11. Rotavirus Infection Therapeutics Market Drivers
Table 12. Rotavirus Infection Therapeutics Market Challenges
Table 13. Rotavirus Infection Therapeutics Market Restraints
Table 14. Global Rotavirus Infection Therapeutics Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Rotavirus Infection Therapeutics Market Share by Players (2019-2024)
Table 16. Global Top Rotavirus Infection Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rotavirus Infection Therapeutics as of 2023)
Table 17. Ranking of Global Top Rotavirus Infection Therapeutics Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Rotavirus Infection Therapeutics Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Rotavirus Infection Therapeutics Product Solution and Service
Table 21. Date of Enter into Rotavirus Infection Therapeutics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Rotavirus Infection Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Rotavirus Infection Therapeutics Revenue Market Share by Type (2019-2024)
Table 25. Global Rotavirus Infection Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Rotavirus Infection Therapeutics Revenue Market Share by Type (2025-2030)
Table 27. Global Rotavirus Infection Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Rotavirus Infection Therapeutics Revenue Market Share by Application (2019-2024)
Table 29. Global Rotavirus Infection Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Rotavirus Infection Therapeutics Revenue Market Share by Application (2025-2030)
Table 31. North America Rotavirus Infection Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Rotavirus Infection Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Rotavirus Infection Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Rotavirus Infection Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Rotavirus Infection Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Rotavirus Infection Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Rotavirus Infection Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Rotavirus Infection Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Rotavirus Infection Therapeutics Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Rotavirus Infection Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Rotavirus Infection Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Rotavirus Infection Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Rotavirus Infection Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Rotavirus Infection Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Rotavirus Infection Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 46. GlaxoSmithKline Company Detail
Table 47. GlaxoSmithKline Business Overview
Table 48. GlaxoSmithKline Rotavirus Infection Therapeutics Product
Table 49. GlaxoSmithKline Revenue in Rotavirus Infection Therapeutics Business (2019-2024) & (US$ Million)
Table 50. GlaxoSmithKline Recent Development
Table 51. Bharat Biotech Company Detail
Table 52. Bharat Biotech Business Overview
Table 53. Bharat Biotech Rotavirus Infection Therapeutics Product
Table 54. Bharat Biotech Revenue in Rotavirus Infection Therapeutics Business (2019-2024) & (US$ Million)
Table 55. Bharat Biotech Recent Development
Table 56. Curevac Company Detail
Table 57. Curevac Business Overview
Table 58. Curevac Rotavirus Infection Therapeutics Product
Table 59. Curevac Revenue in Rotavirus Infection Therapeutics Business (2019-2024) & (US$ Million)
Table 60. Curevac Recent Development
Table 61. Ology Bioservices Company Detail
Table 62. Ology Bioservices Business Overview
Table 63. Ology Bioservices Rotavirus Infection Therapeutics Product
Table 64. Ology Bioservices Revenue in Rotavirus Infection Therapeutics Business (2019-2024) & (US$ Million)
Table 65. Ology Bioservices Recent Development
Table 66. BioKangtai Company Detail
Table 67. BioKangtai Business Overview
Table 68. BioKangtai Rotavirus Infection Therapeutics Product
Table 69. BioKangtai Revenue in Rotavirus Infection Therapeutics Business (2019-2024) & (US$ Million)
Table 70. BioKangtai Recent Development
Table 71. Research Programs/Design for This Report
Table 72. Key Data Information from Secondary Sources
Table 73. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Rotavirus Infection Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Rotavirus Infection Therapeutics Market Share by Type: 2023 VS 2030
Figure 3. Oral Drug Features
Figure 4. Injiectable Drug Features
Figure 5. Global Rotavirus Infection Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Rotavirus Infection Therapeutics Market Share by Application: 2023 VS 2030
Figure 7. Hospital Pharmacies Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Online Pharmacies Case Studies
Figure 10. Rotavirus Infection Therapeutics Report Years Considered
Figure 11. Global Rotavirus Infection Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Rotavirus Infection Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Rotavirus Infection Therapeutics Market Share by Region: 2023 VS 2030
Figure 14. Global Rotavirus Infection Therapeutics Market Share by Players in 2023
Figure 15. Global Top Rotavirus Infection Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rotavirus Infection Therapeutics as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Rotavirus Infection Therapeutics Revenue in 2023
Figure 17. North America Rotavirus Infection Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Rotavirus Infection Therapeutics Market Share by Country (2019-2030)
Figure 19. United States Rotavirus Infection Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Rotavirus Infection Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Rotavirus Infection Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Rotavirus Infection Therapeutics Market Share by Country (2019-2030)
Figure 23. Germany Rotavirus Infection Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Rotavirus Infection Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Rotavirus Infection Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Rotavirus Infection Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Rotavirus Infection Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Rotavirus Infection Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Rotavirus Infection Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Rotavirus Infection Therapeutics Market Share by Region (2019-2030)
Figure 31. China Rotavirus Infection Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Rotavirus Infection Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Rotavirus Infection Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Rotavirus Infection Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Rotavirus Infection Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Rotavirus Infection Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Rotavirus Infection Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Rotavirus Infection Therapeutics Market Share by Country (2019-2030)
Figure 39. Mexico Rotavirus Infection Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Rotavirus Infection Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Rotavirus Infection Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Rotavirus Infection Therapeutics Market Share by Country (2019-2030)
Figure 43. Turkey Rotavirus Infection Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Rotavirus Infection Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. GlaxoSmithKline Revenue Growth Rate in Rotavirus Infection Therapeutics Business (2019-2024)
Figure 46. Bharat Biotech Revenue Growth Rate in Rotavirus Infection Therapeutics Business (2019-2024)
Figure 47. Curevac Revenue Growth Rate in Rotavirus Infection Therapeutics Business (2019-2024)
Figure 48. Ology Bioservices Revenue Growth Rate in Rotavirus Infection Therapeutics Business (2019-2024)
Figure 49. BioKangtai Revenue Growth Rate in Rotavirus Infection Therapeutics Business (2019-2024)
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
